Trevi Therapeutics, Inc. (TRVI)
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
11 Apr 2022
Chang Carmen
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428+52%
3,580,526
$1.90
$6,802,999.00
BUY
11 Apr 2022
Behbahani Ali
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
10,421,428+52%
3,580,526
$1.90
$6,802,999.00
BUY
9 May 2019
Sonsini Peter W.
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
BARRIS PETER J
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Chang Carmen
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
MOTT DAVID M
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
SANDELL SCOTT D
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Behbahani Ali
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
MAKOWER JOSHUA
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
BASKETT FOREST
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
BUY
9 May 2019
Makhzoumi Mohamad
10% Owner
Trevi Therapeutics, Inc.
(TRVI)
2,938,562+570%
2,500,000
$10.00
$25,000,000.00
Home